At Valinor, we are revolutionizing drug development with advanced machine learning models designed to automate the entire process—from identifying drug targets to optimizing clinical trials.
Our advanced generative perturbation models predict drug efficacy, gene interactions, and combinatorial effects—saving time, reducing costs, and improving outcomes.
Virtually screen compounds before lab testing. Reduce trial-and-error costs and focus on the most promising leads.
Virtually screen compounds before lab testing. Reduce trial-and-error costs and focus on the most promising leads.
Virtually screen compounds before lab testing. Reduce trial-and-error costs and focus on the most promising leads.
Virtually screen compounds before lab testing. Reduce trial-and-error costs and focus on the most promising leads.
Virtually screen compounds before lab testing. Reduce trial-and-error costs and focus on the most promising leads.
From lead selection to patient stratification, Valinor enhances decision-making and accelerates breakthroughs.
Predict small molecule efficacy before lab work to prioritize leads and reduce R&D costs.
.svg)
Benchmark your drug’s performance against competitors and uncover synergy opportunities.
.svg)
Identify ideal patient cohorts for clinical trials to improve outcomes and minimize regulatory risks.
.svg)
Discover new indications for existing compounds to accelerate time-to-market and maximize ROI.
By combining generative ML with clinically matched datasets, Valinor helps you solve the toughest challenges in drug development—before you ever run a single assay.
Get Started for Free
